{"id":"W4213247158","doi":"10.1016/s1470-2045(22)00017-1","title":"Pain and health-related quality of life with olaparib versus physician's choice of next-generation hormonal drug in patients with metastatic castration-resistant prostate cancer with homologous recombination repair gene alterations (PROfound): an open-label, randomised, phase 3 trial","year":2022,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Merck Sharp and Dohme; National Institute for Health and Care Research; Merck; AstraZeneca","keywords":"Prostate cancer; Homologous recombination; Olaparib; Drug; Quality of life (healthcare); Hormonal therapy; Gene","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001213382,0.001464725,0.002440893,0.0003150888,0.0003463933,0.001121683,0.0007303036,0.00145339,0.005774744],"category_scores_gemma":[0.001531012,0.0005623587,0.00248271,0.0003654032,0.00124768,0.001012046,0.0004635219,0.003341722,0.0005164108],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007566391,"about_ca_system_score_gemma":0.0007644093,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001155338,"about_ca_topic_score_gemma":0.002387074,"domain_scores_codex":[0.9994506,0.0003045305,0.00002338918,0.00009156684,0.00003441619,0.00009548335],"domain_scores_gemma":[0.9991269,0.0003768168,0.0001768851,0.00005415739,0.00002950367,0.0002358267],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9808646,0.00384932,0.0007355813,0.0003686436,0.0007830241,0.00002066124,0.00003962412,0.0004575939,0.0009920353,0.00007252408,0.0002716329,0.01154477],"study_design_scores_gemma":[0.9118695,0.08398251,0.002443648,0.00002925344,0.0004950214,0.00003069632,0.00003610806,0.000460528,0.0001979145,0.0001869081,0.0002501188,0.00001783447],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9934521,0.003431342,0.000252242,0.0004457211,0.0002861721,0.00060311,0.000480398,0.00003721184,0.001011838],"genre_scores_gemma":[0.9954781,0.001283861,0.0005435221,0.0004110933,0.0002986008,0.0006505285,0.0003725771,0.000008086284,0.0009536003],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005774744,"threshold_uncertainty_score":0.0193184,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2004369039789577,"score_gpt":0.4288075307856609,"score_spread":0.2283706268067031,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}